In Systemic Sclerosis (SSc), an autoimmune disorder characterized by important vascular impairments and multiorgan severe failure (105), CXCL10 and CXCL11 can discriminate those subjects developing SSc from an initial “lighter” condition of very early diagnosis of SSc (VEDOSS) (106). Here, CXCL11 is linked to systemic sclerosis.